357 related articles for article (PubMed ID: 25169971)
1. Attenuated development of cardiac fibrosis in left ventricular pressure overload by SM16, an orally active inhibitor of ALK5.
Engebretsen KV; Skårdal K; Bjørnstad S; Marstein HS; Skrbic B; Sjaastad I; Christensen G; Bjørnstad JL; Tønnessen T
J Mol Cell Cardiol; 2014 Nov; 76():148-57. PubMed ID: 25169971
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of SMAD2 phosphorylation preserves cardiac function during pressure overload.
Bjørnstad JL; Skrbic B; Marstein HS; Hasic A; Sjaastad I; Louch WE; Florholmen G; Christensen G; Tønnessen T
Cardiovasc Res; 2012 Jan; 93(1):100-10. PubMed ID: 22049534
[TBL] [Abstract][Full Text] [Related]
3. SM16, an orally active TGF-beta type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model.
Fu K; Corbley MJ; Sun L; Friedman JE; Shan F; Papadatos JL; Costa D; Lutterodt F; Sweigard H; Bowes S; Choi M; Boriack-Sjodin PA; Arduini RM; Sun D; Newman MN; Zhang X; Mead JN; Chuaqui CE; Cheung HK; Zhang X; Cornebise M; Carter MB; Josiah S; Singh J; Lee WC; Gill A; Ling LE
Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):665-71. PubMed ID: 18202322
[TBL] [Abstract][Full Text] [Related]
4. An orally active small molecule TGF-beta receptor I antagonist inhibits the growth of metastatic murine breast cancer.
Rausch MP; Hahn T; Ramanathapuram L; Bradley-Dunlop D; Mahadevan D; Mercado-Pimentel ME; Runyan RB; Besselsen DG; Zhang X; Cheung HK; Lee WC; Ling LE; Akporiaye ET
Anticancer Res; 2009 Jun; 29(6):2099-109. PubMed ID: 19528470
[TBL] [Abstract][Full Text] [Related]
5. Lack of collagen VIII reduces fibrosis and promotes early mortality and cardiac dilatation in pressure overload in mice.
Skrbic B; Engebretsen KV; Strand ME; Lunde IG; Herum KM; Marstein HS; Sjaastad I; Lunde PK; Carlson CR; Christensen G; Bjørnstad JL; Tønnessen T
Cardiovasc Res; 2015 Apr; 106(1):32-42. PubMed ID: 25694587
[TBL] [Abstract][Full Text] [Related]
6. Moderate Loss of the Extracellular Matrix Proteoglycan Lumican Attenuates Cardiac Fibrosis in Mice Subjected to Pressure Overload.
Mohammadzadeh N; Melleby AO; Palmero S; Sjaastad I; Chakravarti S; Engebretsen KVT; Christensen G; Lunde IG; Tønnessen T
Cardiology; 2020; 145(3):187-198. PubMed ID: 31968347
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor.
Sakata Y; Chancey AL; Divakaran VG; Sekiguchi K; Sivasubramanian N; Mann DL
Basic Res Cardiol; 2008 Jan; 103(1):60-8. PubMed ID: 18034274
[TBL] [Abstract][Full Text] [Related]
8. Targeting the transforming growth factor (TGF)-β cascade in the remodeling heart: benefits and perils.
Frangogiannis NG
J Mol Cell Cardiol; 2014 Nov; 76():169-71. PubMed ID: 25218305
[No Abstract] [Full Text] [Related]
9. MicroRNA-101a suppresses fibrotic programming in isolated cardiac fibroblasts and in vivo fibrosis following trans-aortic constriction.
Zhou Y; Shiok TC; Richards AM; Wang P
J Mol Cell Cardiol; 2018 Aug; 121():266-276. PubMed ID: 30053527
[TBL] [Abstract][Full Text] [Related]
10. Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction.
Tan SM; Zhang Y; Connelly KA; Gilbert RE; Kelly DJ
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1415-25. PubMed ID: 20154262
[TBL] [Abstract][Full Text] [Related]
11. The extracellular matrix proteoglycan lumican improves survival and counteracts cardiac dilatation and failure in mice subjected to pressure overload.
Mohammadzadeh N; Lunde IG; Andenæs K; Strand ME; Aronsen JM; Skrbic B; Marstein HS; Bandlien C; Nygård S; Gorham J; Sjaastad I; Chakravarti S; Christensen G; Engebretsen KVT; Tønnessen T
Sci Rep; 2019 Jun; 9(1):9206. PubMed ID: 31235849
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor (TGF)-β type I receptor kinase (ALK5) inhibitor alleviates profibrotic TGF-β1 responses in fibroblasts derived from Peyronie's plaque.
Piao S; Choi MJ; Tumurbaatar M; Kim WJ; Jin HR; Shin SH; Tuvshintur B; Yin GN; Song JS; Kwon MH; Lee SJ; Han JY; Kim SJ; Ryu JK; Suh JK
J Sex Med; 2010 Oct; 7(10):3385-95. PubMed ID: 20233292
[TBL] [Abstract][Full Text] [Related]
13. BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery.
Merino D; Villar AV; García R; Tramullas M; Ruiz L; Ribas C; Cabezudo S; Nistal JF; Hurlé MA
Cardiovasc Res; 2016 Jun; 110(3):331-45. PubMed ID: 27068510
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis.
Khalil H; Kanisicak O; Prasad V; Correll RN; Fu X; Schips T; Vagnozzi RJ; Liu R; Huynh T; Lee SJ; Karch J; Molkentin JD
J Clin Invest; 2017 Oct; 127(10):3770-3783. PubMed ID: 28891814
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure.
Verjans R; Peters T; Beaumont FJ; van Leeuwen R; van Herwaarden T; Verhesen W; Munts C; Bijnen M; Henkens M; Diez J; de Windt LJ; van Nieuwenhoven FA; van Bilsen M; Goumans MJ; Heymans S; González A; Schroen B
Hypertension; 2018 Feb; 71(2):280-288. PubMed ID: 29255073
[TBL] [Abstract][Full Text] [Related]
16. Qishen granule attenuates cardiac fibrosis by regulating TGF-β /Smad3 and GSK-3β pathway.
Zeng Z; Wang Q; Yang X; Ren Y; Jiao S; Zhu Q; Guo D; Xia K; Wang Y; Li C; Wang W
Phytomedicine; 2019 Sep; 62():152949. PubMed ID: 31102891
[TBL] [Abstract][Full Text] [Related]
17. Sirtuin 1 activation attenuates cardiac fibrosis in a rodent pressure overload model by modifying Smad2/3 transactivation.
Bugyei-Twum A; Ford C; Civitarese R; Seegobin J; Advani SL; Desjardins JF; Kabir G; Zhang Y; Mitchell M; Switzer J; Thai K; Shen V; Abadeh A; Singh KK; Billia F; Advani A; Gilbert RE; Connelly KA
Cardiovasc Res; 2018 Oct; 114(12):1629-1641. PubMed ID: 29800064
[TBL] [Abstract][Full Text] [Related]
18. Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway.
Xiao H; Ma X; Feng W; Fu Y; Lu Z; Xu M; Shen Q; Zhu Y; Zhang Y
Cardiovasc Res; 2010 Aug; 87(3):504-13. PubMed ID: 20200042
[TBL] [Abstract][Full Text] [Related]
19. Identification of TGF-β receptor-1 as a key regulator of carbon nanotube-induced fibrogenesis.
Mishra A; Stueckle TA; Mercer RR; Derk R; Rojanasakul Y; Castranova V; Wang L
Am J Physiol Lung Cell Mol Physiol; 2015 Oct; 309(8):L821-33. PubMed ID: 26472812
[TBL] [Abstract][Full Text] [Related]
20. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
Lian R; Chen Y; Xu Z; Zhang X
Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
